Biotage AB (BIOTa.ST) and Peptide Synthesis
5/13/2013
More...
|
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia
5/10/2013
More...
|
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies
5/6/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case
4/30/2013
More...
|
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology
4/30/2013
More...
|
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins
4/22/2013
More...
|
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant
4/22/2013
More...
|
ARTES Biotechnology Issued New Patent in Australia for VLP Technology
4/22/2013
More...
|
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device
4/22/2013
More...
|
Celsus Therapeutics Announces Notification of Patents Granted
4/17/2013
More...
|
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™
4/17/2013
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand
4/17/2013
More...
|
Starpharma Holdings Ltd Granted New Drug Delivery Patents
4/17/2013
More...
|
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month
4/15/2013
More...
|
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S.
4/2/2013
More...
|
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case
4/1/2013
More...
|
European Patent Office to Grant Patent for Macrocure's CureXcell®
3/21/2013
More...
|
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update
3/15/2013
More...
|
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens
3/11/2013
More...
|
Alchemia Granted Key U.S. Patent
3/6/2013
More...
|
India Rejects Bayer AG (BAY.F) Plea Against Cheap Cancer Drug
3/5/2013
More...
|
Additional Patent Granted in China for BioDiem Ltd. (BDM.AX)'s Antimicrobial
2/21/2013
More...
|
BioIndustry Association Release: New Patent Court Makes UK Natural European Home for Global Life Science Businesses
2/19/2013
More...
|
Bristol-Myers Squibb Company (BMY): Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva Pharmaceutical Industries Limited (TEVA) to Benefit
2/13/2013
More...
|
Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease"
2/12/2013
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease
2/8/2013
More...
|
MorphoSys AG Receives First Patent on Novel Antibody Platform Ylanthia in the U.S.
2/8/2013
More...
|
Mesoblast Limited Release: Key Mesenchymal Precursor Cell Patents Granted in United States and China
2/7/2013
More...
|
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections
2/4/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results
2/1/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa® and FDA Approved MARINE Indication
1/31/2013
More...
|
Amarin Corporation PLC (AMRN) Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results
1/24/2013
More...
|
Anergis Obtains U.S. Patent for Lead Product AllerT
1/23/2013
More...
|
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™
1/22/2013
More...
|
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad U.S. Composition of Matter Patent for ADX71441
1/22/2013
More...
|
Biotage AB (BIOTa.ST) Success in Re-Examination Proceedings
1/16/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication
1/11/2013
More...
|
RedHill Biopharma Ltd. (RDHL) Announces Issuance of New U.S. Patent and Provides Update on RHB-104 for Treatment of Crohn's Disease
1/7/2013
More...
|
Alkermes plc (ALKS) Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate
1/3/2013
More...
|
Suven Life Sciences Ltd Secures 3 Product Patents for Their New Chemical Entities, Inc.'s in Eurasia & Canada
1/2/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa® and FDA Approved MARINE Indication
12/13/2012
More...
|
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment
12/6/2012
More...
|
MorphoSys AG Strengthens Patent Position on anti-CD38 Cancer Program MOR202
12/6/2012
More...
|
Rainbow BioSciences, LLC Target Amarantus BioSciences, Inc. Wins MANF Patent Challenge in Europe
12/5/2012
More...
|
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan
12/5/2012
More...
|
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy
12/4/2012
More...
|
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery
11/28/2012
More...
|
Indian Board Rejects AstraZeneca PLC (AZN)'s Patent Plea on Cancer Drug
11/28/2012
More...
|
Japanese Patent Office to Grant BioDiem Ltd. (BDM.AX) New Patent for BDM-I Antimicrobial
11/21/2012
More...
|
Medgenics, Inc. Granted U.S. Patent for Core Technology Used in Sustained Delivery of Erythropoietin, Aimed at Multi-Billion Dollar Anemia Market
11/21/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication
11/19/2012
More...
|
MediciNova, Inc. Extends MN-166 Patent Position in Europe
11/19/2012
More...
|
Marinomed Biotechnologie GmbH Granted Chinese Patent for Antiviral Polymer
11/19/2012
More...
|
New Patent Covering PROLOR Biotech (PBTH)'s Reversible-Pegylation Platform Technology is Allowed by U.S. Patent Office
11/13/2012
More...
|
India Revokes Roche (RHHBY) Patent in New Blow for Big Pharma
11/5/2012
More...
|
InDex Pharmaceuticals AB Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation
10/24/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa™
10/23/2012
More...
|
Adocia is Extending Its Intellectual Property to New Formulations of Monoclonal Antibodies
10/22/2012
More...
|
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of Its Lead Pre-Clinical Product
10/15/2012
More...
|
Alnylam Pharmaceuticals (ALNY) Announces Tuschl II Key Patent Claims Upheld in Invalidation Trial in Japan
10/9/2012
More...
|
Laurantis Pharma Oy Issued Patent for Cis-UCA as a Treatment for Bladder Cancer
10/9/2012
More...
|
Suven Life Sciences Ltd Bags Pharmexcil's "Platinum Patent Award"
10/4/2012
More...
|
India Revokes Patent for Pfizer Inc. (PFE)'s Sutent
10/4/2012
More...
|
BioLineRx Ltd. Receives Notice of Allowance From USPTO for New Patent on BL-1020, Extending Patent Protection Until 2031
9/24/2012
More...
|
Cardiolynx Receives Patent on Improved Angina Pectoris Drug
9/20/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa™ and FDA Approved MARINE Indication
9/6/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa™ and FDA Approved MARINE Indication
9/5/2012
More...
|
InDex Pharmaceuticals AB Strengthens IP Position for Kappaproct
9/4/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa™ and FDA Approved MARINE Indication
9/4/2012
More...
|
Public Not to be Hit if Natco Pharma Limited Licence Cancelled: Bayer Corporation (BAY)
9/4/2012
More...
|
China Botanic Receives New Patent on Its Comprehensive Method to Enhance the Medicinal Value of Schisandra
8/28/2012
More...
|
U.S. Patent Granted for Verona Pharma's RPL554
8/28/2012
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in Australia, Canada, Korea and New Zealand
8/9/2012
More...
|
BioDiem Ltd. (BDM.AX) Granted European Patent for BDM-I Antimicrobial
8/7/2012
More...
|
DiaGenic ASA: Notice of Allowance of Breast Cancer Patent in Japan
8/3/2012
More...
|
U.S. Patent Office Allows Laurantis Pharma Oy Application for Treatment of Skin Inflammation
8/1/2012
More...
|
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments
7/30/2012
More...
|
Amarin Corporation PLC (AMRN) Receives Notice of Intention to Grant on European Patent
7/25/2012
More...
|
BioAlliance Pharma Extends and Strengthens the Protection of AMEP® With the Grant of Two Patents in the US
7/12/2012
More...
|
BioLineRx Ltd. Receives Notice of Intention to Grant Additional European Patent Covering BL-1020, for the Treatment of Schizophrenia
7/9/2012
More...
|
Novartis AG (NVS) India Patent Case Postponed to August 22
7/9/2012
More...
|
Danisco Wins European Patent Office Appeal as Board Revokes Novozymes A/S (NZYMb.CO) Animal Feed Patent
7/6/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notice of Allowance for Additional U.S. Patent Covering AMR101
7/2/2012
More...
|
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy
6/18/2012
More...
|
PolyTherics Granted Further Patents for TheraPEG™ and GlycoPol™
6/18/2012
More...
|
Bionor Pharma ASA Release: International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, Combining Bionor's Vacc-4x and Vacc-C5
6/7/2012
More...
|
Bionor Pharma ASA Release: International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus
6/7/2012
More...
|
BioLineRx Ltd. Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain
6/5/2012
More...
|
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform
5/31/2012
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Core Technology Patent in New Zealand
5/29/2012
More...
|
Amarin Corporation PLC (AMRN) Announces U.S. Patent Issuance for AMR101
5/29/2012
More...
|
Patrys Limited (PATZF.PK) Granted Key Patent for Lead Product -- PAT-SM6
5/24/2012
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia
5/22/2012
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins
5/16/2012
More...
|
New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker
5/15/2012
More...
|
Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology
5/14/2012
More...
|
Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology
5/10/2012
More...
|
BioDiem Ltd. (BDM.AX) Release: BDM-I Patent Position Strengthened With New US Patent Relating to Malaria and Trichomoniasis
5/3/2012
More...
|
Quotient Receives Final Patent Approval for Its Enteriontm Technology – the Industry's Leading Clinical Technology for Investigating Drug Absorption
5/1/2012
More...
|
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents
4/11/2012
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Four New Patents and Allowances in Mexico and Israel
4/9/2012
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in China and Korea
4/3/2012
More...
|
Supreme Court Knocks Back Myriad Genetics, Inc. (MYGN) Patents
3/28/2012
More...
|
Genmab A/S (GEN.CO) Says GlaxoSmithKline (GSK) Settles Patent Case With Genentech (RHHBY)
3/27/2012
More...
|
Ideal Cures Pvt. Ltd. Receives Key US Patent for Sodium Alginate Based Aqueous Film Coating Technology
3/27/2012
More...
|
Moraga Biotechnology Corporation Announces Issuance of Adult Stem Cell Patent for Humans
3/20/2012
More...
|
Silence Therapeutics plc and Other Opponents of Tuschl I Patent Succeed in Limiting Scope and Ambiguity in the Patent
3/9/2012
More...
|
BioLineRx Ltd. Announces Grant of European Patent Covering BL-1020, an Orally Available Treatment for Schizophrenia
3/7/2012
More...
|
Alnylam Pharmaceuticals (ALNY) and the University of Massachusetts Medical School Announce Tuschl I Patent Upheld in European Opposition Proceedings
3/1/2012
More...
|
Genetic Technologies Limited (GTG.AX) Provides Update on U.S. and Australian Gene Patenting Litigation, Case Law and Legislation
2/29/2012
More...
|
GENFIT Corp. (ALGFT) Release: GFT505: New Patents Granted in Major Countries
2/23/2012
More...
|
Hatchtech Extends Patent Protection for DeOvo™ Head Lice Treatment
2/15/2012
More...
|
Precision BioSciences Receives Notice of Intent to Grant for New European Patent Covering Engineered Meganucleases
2/14/2012
More...
|
Plasticell Announces Grant of Fundamental Combicultt Patents in USA and Japan
2/13/2012
More...
|
Sanofi (France) (SAN.PA), Bristol-Myers Squibb Company (BMY) Receive Nearly $445 Million From Apotex Inc. Over Generic Plavix
2/9/2012
More...
|
Suven Life Sciences Ltd Secures 3 Product Patents for Their NCEs in Mexico and USA
2/7/2012
More...
|
Precision BioSciences Announces Allowance of Third U.S. Patent Related to Engineered Meganucleases
1/30/2012
More...
|
Affectis Pharmaceuticals AG Granted Patent for AFC-5128, Other P2X7 Antagonists
1/25/2012
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins
1/24/2012
More...
|
With Final Documentation Submitted for International Patent Applications, Bionor Pharma ASA Sees Promise of Two Core Platform Technologies
1/23/2012
More...
|
MorphoSys AG Strengthens Patent Position on MOR202 Program
1/23/2012
More...
|
Seegene, Inc. Strengthens Position in Multiplex PCR With Award of United States Patent for Dual Priming Oligonucleotide (DPO(TM)) Technology
1/17/2012
More...
|
Biotage AB (BIOTa.ST) is Subject to Extended Patent Litigation in the US
1/12/2012
More...
|
Pulmatrix Announces Grant of Patent Supporting Its Novel Pulmonary Drug Therapies
1/5/2012
More...
|
European Patent Office Upholds Synergy Pharmaceuticals’ Grant of Claims to Plecanatide
1/4/2012
More...
|
Nuvilex Associate Expands Ownership of Patents to Include Production of Therapeutic Antibodies
12/20/2011
More...
|
Ablynx Adds Another Key Patent to Its Expanding Patent Estate Around Half-Life Extension
12/15/2011
More...
|
Silence Therapeutics plc Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
12/12/2011
More...
|
Pharming Group (PHGUF.PK) Granted U.S. Patent on C1 Inhibitor Use in Ischemia Reperfusion Injury Indications
12/12/2011
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Australia and Canada
12/8/2011
More...
|
Silence Therapeutics plc Announces Positive Outcome From Oral Hearing at the European Patent Office
12/7/2011
More...
|
MEDA: Astepro Patent Granted
12/6/2011
More...
|
AusBiotech Ltd. Supports Government's Response on Patents
11/28/2011
More...
|
PRANA Biotechnology (PRAN) Secures Key Patent for Parkinson's Drug PBT434 in the United States
11/28/2011
More...
|
Genmab A/S (GEN.CO) Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
11/17/2011
More...
|
ImmunAid Pty.Ltd. Release: Break-Through Invention for Treating Cancer
11/7/2011
More...
|
Adamis Pharmaceuticals Prostate Cancer Drug APC-100 Receives Allowance for Patent in Canada
11/3/2011
More...
|
Revotar Biopharmaceuticals Receives New Composition-of-Matter Patent for Bimosiamose in the US
11/2/2011
More...
|
Critical Outcome Technologies Inc. Receives U.S. Patent for Promising Oncology Compound COTI-2
10/13/2011
More...
|
Allenex AB: XM-ONE Receives US Patent Protection
10/13/2011
More...
|
Pfizer Inc. (PFE) Settles with Teva Pharmaceutical Industries Limited (TEVA) Over Lipitor in UK; Deal Keeps Generic Lipitor at Bay to May 2012
10/11/2011
More...
|
DiaGenic ASA: Notice of Allowance of United States Family 3 Breast Cancer Patent
10/6/2011
More...
|
AstraZeneca PLC (AZN) Climbs as it Settles Key Seroquel Patent Dispute with Handa Pharmaceuticals
9/30/2011
More...
|
Australia's Agenix Limited Files Key Patent Application for China Hepatitis Drug
9/27/2011
More...
|
Sanofi (France) (SASY.PA) Wins U.S. Cancer Drug Patent Ruling
9/19/2011
More...
|
Eisai Company, Ltd. (ESALY.PK) Says Aricept Patent is Upheld by Japan Court
9/14/2011
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their New Chemical Entities, Inc. in Australia and New Zealand
9/6/2011
More...
|
Novartis AG Patent Dispute in India Heats Up
9/6/2011
More...
|
DiaGenic ASA: Grant of Australian Family 3 Patent
9/2/2011
More...
|
Australian Anti-Cancer Drug Company, Immune System Therapeutics Limited Granted Important New Patent
9/1/2011
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Court Adopts All Relevant Teva Claim Construction Interpretations in Copaxone® Patent Infringement Case Against Sandoz, Inc./Momenta Pharmaceuticals, Inc. (MNTA) and Mylan Pharmaceuticals, Inc. (MYL)/Natco Pharma Limited; Court Denies Mylan’s Summary Judgment Motion of Invalidity
8/29/2011
More...
|
Trophos Awarded Key US Patent Covering Use of Novel Cardioprotective Compound, TRO40303
8/23/2011
More...
|
Angle PLC Release: Parsortix, Inc. Granted US Patent
8/23/2011
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in the Key Markets in the World
8/18/2011
More...
|
Pfizer Inc. (PFE) Wins Viagra Patent Battle Against Teva Pharmaceutical Industries Limited (TEVA)
8/15/2011
More...
|
Agennix AG Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer
8/10/2011
More...
|
How Novartis AG Hopes To Cope With Diovan Patent Expiration
8/5/2011
More...
|
Gilead Sciences, Inc. (GILD) Kickstarts Patent Pool for AIDS Drugs, Agrees to Let Generic Companies like Mylan Inc. (MYL), Ranbaxy Laboratories (RANBAXY.BO) Make Them
7/12/2011
More...
|
BioAlliance Strengthens the Protection of Livatag(R) (doxorubicin Transdrug(TM) with the Grant of a European Patent
7/12/2011
More...
|
BioAlliance Pharma Strengthens the Protection of Livatag(R) (Doxorubicin Transdrug(TM)) With the Grant of a European Patent
7/11/2011
More...
|
Suven Life Sciences Ltd Secures 2 Product Patents for their NCEs in the Key Markets in the World
6/20/2011
More...
|
BioAlliance Pharma Strengthens its Proprietary Technologies with the Grant of Its Lauriad(TM) Patents in Asia and With the Transfer of Setofilm(R) Back to APR Applied Pharma Research S.A., the Owner of the Technology
6/10/2011
More...
|
Granting of U.S. Patent Further Extends Protection of Pharming Group (PHGUF.PK)'s Core Technology Platform
6/10/2011
More...
|
ANTISENSE PHARMA GmbH Release: Innovative Drug Development Covers More Than Just The Substance
6/1/2011
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in Several Key Markets in the World
5/26/2011
More...
|
Mesoblast Limited Key Patents Granted In United States Strengthen Commercial Rights And Broaden Clinical Indications
5/24/2011
More...
|
Cleveland Biolabs Inc. (CBLI) Receives Notice of Patent Allowance From Japan for CBLB502
5/23/2011
More...
|
Deinove Confirms the Allowance of its Foundation Patent by the European Patent Office
5/19/2011
More...
|
China Awards Patent to ThalesNano's Revolutionary Lab Ozonolysis System, the O-Cube(TM)
5/12/2011
More...
|
SYGNIS Pharma AG Strengthens its KIBRA-Project: First Patents Announced for Europe and the USA
5/5/2011
More...
|
P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug
4/26/2011
More...
|
Suven Life Sciences Ltd Secures 7 Product Patents for Their Nces in Several Key Markets in the World
4/26/2011
More...
|
GW Pharmaceuticals Release: US Patent Granted for Sativex(R) in Cancer Pain
4/20/2011
More...
|
U.S. Patent and Trademark Office (USPTO) Issues QRxPharma Pty Ltd. a New Patent for MoxDuo(R) IR
4/14/2011
More...
|
Key Patrys Limited (PATZF.PK) Patents Allowed for Multiple Products in U.S., Europe and Japan
4/13/2011
More...
|
KINAXO Biotechnologies Announces European Patent Granted for its Chemical Proteomics Applications
4/11/2011
More...
|
PRANA Biotechnology (PRAN) Secures Key PBT2 Patent in Japan and Completes Core IP Suite
4/11/2011
More...
|
BioLineRx Ltd. Receives Notice of Allowance From USPTO for Patent Covering BL-1020 Drug for Treatment of Schizophrenia
4/5/2011
More...
|
Asterand plc (ATD.L) Awarded Key Patents on the BioMAP Technology
3/31/2011
More...
|
Agennix AG Announces Issuance of U.S. Patent Covering Use of Talactoferrin to Treat Non-Small Cell Lung Cancer and Renal Cell Carcinoma
3/23/2011
More...
|
Benitec Limited (BLT.AX) RNAi Patent Update
3/22/2011
More...
|
ProtAffin AG Granted Patent in EU for CellJammer(R) Discovery Technology
3/14/2011
More...
|
Patent Plethora in 2010 Breaks Record for Biocitech SAS Technology Park Residents
3/1/2011
More...
|
Univercell-Biosolutions Acquires Ips Cell Patent License from iPS Academia Japan, Inc.
2/24/2011
More...
|
Living Cell Technologies Ltd.'s World-Leading Encapsulating Technology Granted Vital Australian Patent
2/24/2011
More...
|
Mologen AG (MOLGF.PK): Cell-Based Gene Therapy against Cancer (MGN1601) Granted Patent Protection in Europe
2/23/2011
More...
|
NovaBiotics Ltd - Patents Granted in Key Territories as Novexatin(R) Moves Closer to Further Clinical Development and Commercialisation
2/22/2011
More...
|
Patent Update: Strengthening and Expansion of Benitec Limited (BLT.AX)’s Dominant Patent Position in RNAi
2/17/2011
More...
|
Biocrea Announces Novel Treatment Opportunities for CNS Diseases
2/16/2011
More...
|
SYGNIS Pharma AG Strengthens Patent Position on AX200 for the Treatment of Neurodegenerative Diseases
2/9/2011
More...
|
MorphoSys AG Strengthens Patent Position on Lead Program MOR103
2/7/2011
More...
|
RecipharmCobra Biologics, a Division of Recipharm AB, Announces Granted Patents on its Bacterial Genetic Modification Technology (Xer-cise(TM))
2/2/2011
More...
|
Hybrigenics Receives Green Light for its European Patent on High Therapeutic Doses of Inecalcitol
1/24/2011
More...
|
Novo Nordisk A/S (NVO) Intends to Appeal Adverse Ruling in Prandin® (repaglinide) Patent Case
1/20/2011
More...
|
Serodus AS Issued Japanese Patent Covering ORL-1 Receptor Agonist SER100 for Isolated Systolic Hypertension
1/18/2011
More...
|
Natco Pharma Limited Seeks 'Compulsory License' For Copy Of Pfizer Inc. (PFE) Drug
1/5/2011
More...
|
Abbott Laboratories (ABT)' Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies
1/4/2011
More...
|
Suven Life Sciences Ltd Secures 2 Product Patents For Their NCEs
12/30/2010
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents For Their NCEs
12/28/2010
More...
|
Deinove Foundation Patent is Soon to be Granted by the European Patent Office
12/21/2010
More...
|